Jin Bong Choi1, Jung Ho Kim2, Sung-Hoo Hong3, Kyung-Do Han4, U-Syn Ha5,6. 1. Department of Urology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 2. Department of Urology, Dongnam Institute of Radiological & Medical Sciences, Cancer Center, Busan, Republic of Korea. 3. Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 4. Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 5. Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ushamd@catholic.ac.kr. 6. The Cancer Research Institute, The Catholic University of Korea, Seoul, Republic of Korea. ushamd@catholic.ac.kr.
Abstract
PURPOSE: The previous epidemiological studies about the associations between obesity and bladder cancer risk have reported inconsistent results. Therefore, we analyzed whether the abdominal obesity effected on the risk of developing bladder cancer according to body mass index (BMI) using nationally representative data from the National Health Insurance System (NHIS). PATIENTS AND METHODS: Among people who underwent at least one health examination from 2009 to 2012 in Korea, 11,823,876 men without a previous diagnosis of bladder cancer were followed up until December 2015. Multiple Cox regression analysis was conducted to determine the hazard ratio (HR) and 95% confidence interval (CI) for the association between bladder cancer and BMI or waist circumference (WC). RESULTS: Significant upward trends in the risk of bladder cancer were observed with increasing BMI or WC according to the multivariate-adjusted model. However, the association between BMI and bladder cancer is influenced by the presence of abdominal obesity. In the group with WC < 90 cm, there was no significant change in the HRs for bladder cancer development beyond the reference BMI. In contrast, the HRs for bladder cancer showed statistically significant increase as the BMI increased beyond the reference BMI in the group with WC ≥ 90 cm. CONCLUSION: This population-based study showed that increasing BMI and increasing WC were risk factors for developing bladder cancer in men, independent of confounding variables. However, there was a discrepancy in the trend of bladder cancer development according to BMI between the groups with abdominal obesity and without abdominal obesity.
PURPOSE: The previous epidemiological studies about the associations between obesity and bladder cancer risk have reported inconsistent results. Therefore, we analyzed whether the abdominal obesity effected on the risk of developing bladder cancer according to body mass index (BMI) using nationally representative data from the National Health Insurance System (NHIS). PATIENTS AND METHODS: Among people who underwent at least one health examination from 2009 to 2012 in Korea, 11,823,876 men without a previous diagnosis of bladder cancer were followed up until December 2015. Multiple Cox regression analysis was conducted to determine the hazard ratio (HR) and 95% confidence interval (CI) for the association between bladder cancer and BMI or waist circumference (WC). RESULTS: Significant upward trends in the risk of bladder cancer were observed with increasing BMI or WC according to the multivariate-adjusted model. However, the association between BMI and bladder cancer is influenced by the presence of abdominal obesity. In the group with WC < 90 cm, there was no significant change in the HRs for bladder cancer development beyond the reference BMI. In contrast, the HRs for bladder cancer showed statistically significant increase as the BMI increased beyond the reference BMI in the group with WC ≥ 90 cm. CONCLUSION: This population-based study showed that increasing BMI and increasing WC were risk factors for developing bladder cancer in men, independent of confounding variables. However, there was a discrepancy in the trend of bladder cancer development according to BMI between the groups with abdominal obesity and without abdominal obesity.
Entities:
Keywords:
Bladder cancer; Body mass index; Waist circumference
Authors: A C Carlsson; U Riserus; J Ärnlöv; Y Borné; K Leander; B Gigante; M-L Hellénius; M Bottai; U de Faire Journal: Nutr Metab Cardiovasc Dis Date: 2014-02-12 Impact factor: 4.222
Authors: Francesco Cantiello; Antonio Cicione; Andrea Salonia; Riccardo Autorino; Cosimo De Nunzio; Alberto Briganti; Giorgio Gandaglia; Paolo Dell'Oglio; Paolo Capogrosso; Rocco Damiano Journal: Int J Urol Date: 2014-10-23 Impact factor: 3.369
Authors: Neal D Freedman; Debra T Silverman; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet Journal: JAMA Date: 2011-08-17 Impact factor: 56.272
Authors: A Juul; P Bang; N T Hertel; K Main; P Dalgaard; K Jørgensen; J Müller; K Hall; N E Skakkebaek Journal: J Clin Endocrinol Metab Date: 1994-03 Impact factor: 5.958
Authors: Nisha Hariharan; Keith A Ashcraft; Robert S Svatek; Carolina B Livi; Desiree Wilson; Dharam Kaushik; Robin J Leach; Teresa L Johnson-Pais Journal: J Obes Date: 2018-05-20
Authors: Su Zhang; Jian-Bing Wang; Huan Yang; Jin-Hu Fan; You-Lin Qiao; Philip R Taylor Journal: Cancer Epidemiol Date: 2020-02-09 Impact factor: 2.984